CHENNAI, December 6, 2017 /PRNewswire/ --
For the first time in the world, a major innovation
Dr. Agarwal's Eye Hospital, India's leading
(Photo: http://mma.prnewswire.com/media/616109/Dr_Agarwal_s_Eye_Hospital_Innovation_in_Vitreous_Removal.jpg )
Talking about this innovation, Dr. Amar Agarwal, Chairman, Dr. Agarwal's Eye Hospital said, "The technology for performing vitrectomy has changed little over the last 40 years when the first single port, multi-functional pneumatic cutter was invented. With this patented technology, this would be the first and only hypersonic device for vitreous removal which is US FDA approved. It would use a novel, single needle design, a continuous open-port system and would use highly localized tissue liquefaction zone at the edge of the port to liquefy vitreous for exceptional control during tissue removal."
The faster vitreous is cut, the less is the amount of traction on it and therefore there is decreased risk on the retina. Modern vitrectomy technology today operates at speeds up to 5,000-7,500 cuts per minute. Vitesse would enable to increase the cutting rate to approximately 1.7 million cuts per minute with the purpose to significantly decrease the amount of vitreous traction that occurs in vitrectomy.
Mr. Sanjay Bhutani, Managing Director, Bausch & Lomb India Pvt. Ltd. quoted that Vitesse hypersonic vitrectomy system, which represents the first major vitreous removal innovation in 40 years, is expected to be commercially available exclusively on Bausch & Lomb's new Stellaris Elite[TM] Vision Enhancement System sometime in 2018. More details could be obtained from the Company website: http://www.bausch.com/our-company/recent-news/id/2372/4262017-wednesday.
The next-generation Stellaris Elite[TM] has been primarily designed for surgical platform for retinal surgery, which would provide ultimate control and efficiency during the procedure and would offer many new cutting-edge innovations and greater opportunities to add upgrades and enhancements in future. Vitesse would be able to provide a safer option to patients as it would help remove vitreous efficiently with less energy usage during retinal surgeries which would minimize the chances of injury. Faster cut rates and liquefaction of vitreous should ensure less vitreoretinal traction thereby minimizing complications such as retinal detachment, while performing procedures close to the retina. Vitesse would give surgeons the options of doing vitrectomy in more complicated cases of the retina, which would be on account of its better control and efficiency.
About Dr. Agarwal's Eye Hospital:
Dr. Agarwal's Eye Hospital, a comprehensive eye hospital offering a one-stop solution for eye ailments; was started in the year 1957. Now the hospital is in its 57th year of offering quality services in eye care. It has 15 branches in Chennai and a visible footprint in the states of Tamil Nadu, Telangana, Andhra Pradesh, Karnataka, Odisha, Andaman and Rajasthan. A tertiary eye care centre at Mauritius marks its first step towards establishing an international presence extended up to 13 branches covering the Indian Ocean region, African countries and East Asia.
The hospital has received various awards for its inventions and services. In March 2006, Late Dr. J Agarwal, Founder-Chairman was awarded Padma Bhushan by the former President of India, Dr. APJ Abdul Kalam for his dedicated services to the poor and downtrodden. The hospital received visibility in the global arena for its inventions - Micro-Phakonit (Cataract surgery with 0.7 mm size incision) in 1999 and 'Glued Intraocular Lens Implant' performed on a 4 year old girl in January 2008 by Prof. Amar Agarwal. In February 2009, the world's first Anterior Segment Eye Transplant Surgery was performed on a 4 month old child to treat corneal disorder. In November 2013, for the first time in the world, Dr. Agarwal's Eye Hospital, Chennai transplanted a one year old donor cornea giving a new lease of sight to a 60 year old man through the new technique PDEK (Pre Descemet's Endothelial Keratoplasty).
For more information, visit: http://www.dragarwal.com/
Media Contact: Jayati Meena [email protected] +91-9840168417 Marketing Dr. Agarwal's Eye Hospital
Subscribe to our Free Newsletters!
PUVA or photochemotherapy is used to treat several skin disorders with the help of UV light and the ...
Breathing in unclean air due to increasing air pollution could cause kidney damage with resultant ...
Benign prostatic hyperplasia or enlarged prostate is a noncancerous condition observed in men above ...View All